Ingelheim: Boehringer Ingelheim has obtained positive opinions from the European Medicines Agency (EMA) recommending the granting of marketing authorisations under exceptional circumstances for its avian influenza vaccines VAXXITEK HVT+IBD+H5 and VAXXINACT H5.

Both vaccines immunize birds against the H5 avian influenza virus, which is currently causing outbreaks across Europe.

Avian influenza, commonly referred to as avian flu or bird flu, is a highly contagious disease affecting domestic and wild birds. The H5 strain is one of the most prevalent avian influenza virus strains causing outbreaks in both wildlife and commercial flocks. As avian influenza is a highly regulated and notifiable disease, there is vigilant monitoring. To contain avian influenza outbreaks, large numbers of birds

See Full Page